Free Account Opening + AMC Free Demat
Loading...

Bafna Pharmaceuticals IPO vs First Winner IPO

Comparision between Bafna Pharmaceuticals IPO and First Winner IPO.

IPO Details

Bafna Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE while First Winner IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

  Bafna Pharmaceuticals IPO First Winner IPO
Logo Bafna Pharmaceuticals IPO Logo First Winner IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Fixed Price Issue Book Built Issue
Listing At BSE BSE, NSE
Lead Managers Keynote Financial Services Ltd

Ashika Capital Ltd
Almondz Global Securities Limited
Registrar Cameo Corporate Services Limited Link Intime India Private Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Bafna Pharmaceuticals IPO is up to ₹25.60 Cr whereas the issue size of the First Winner IPO is up to ₹68.75 Cr. The final issue price of Bafna Pharmaceuticals IPO is ₹40.00 per share and of First Winner IPO is ₹125.00 per share.

  Bafna Pharmaceuticals IPO First Winner IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹115.00 per share
Issue Price (Upper) ₹125.00 per share
Issue Price (Final) ₹40.00 per share ₹125.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 50 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 64,00,000 shares 55,00,000 shares
Issue Size Total (Amount) up to ₹25.60 Cr up to ₹68.75 Cr

IPO Timetable

Bafna Pharmaceuticals IPO opens on May 27, 2008, while First Winner IPO opens on Jun 09, 2008. The closing date of Bafna Pharmaceuticals IPO and First Winner IPO is May 30, 2008, and Jun 17, 2008, respectively.

  Bafna Pharmaceuticals IPO First Winner IPO
Anchor Bid Date
Issue Open May 27, 2008 Jun 09, 2008
Issue Close May 30, 2008 Jun 17, 2008
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Bafna Pharmaceuticals IPO P/E ratio is , as compared to First Winner IPO P/E ratio of .

  Bafna Pharmaceuticals IPO First Winner IPO
Financial
ParticularsFor the year/period ended (Rs. in lacs)
 30-Jun-0731-Mar-0731-Mar-0631-Mar-0531-Mar-04
  Total Income432.023861.962136.472662.651521.33
  Profit After Tax (PAT)49.70104.2392.2789.8144.51
ParticularsFor the year/period ended (Rs. in lacs)
 30-June-0731-Mar-0731-Mar-0631-Mar-0531-Mar-0431-Mar-03
  Total Income2057.505554.613827.522787.061834.67244.37
  Profit After Tax (PAT)241.10255.145.879.803.790.42
Promoter Shareholding (Pre-Issue) 71.07% 59.96%
Promoter Shareholding (Post-Issue) 42.6% 41.36%
P/E Ratio
Market Cap
ROE
ROCE 18.95%%
Debt/Equity
EPS
RoNW 10.65%% 13.36%%

Shares Offered

In the Bafna Pharmaceuticals IPO retail investors (RII) are offered while in First Winner IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Bafna Pharmaceuticals IPO and in First Winner IPO.

  Bafna Pharmaceuticals IPO First Winner IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Bafna Pharmaceuticals IPO subscribed in total, whereas First Winner IPO subscribed 1.26x.

  Bafna Pharmaceuticals IPO First Winner IPO
QIB (times) 1.05x
NII (times) 1.84x
Big NII (times)
Small NII (times)
RII (times) 1.32x
Employee (times) 1.08x
Other (times)
Total (times) 1.26x

Comments

Add a public comment...